Molecular mechanism detection of stage I to stage II transition of esophageal squamous cell carcinoma: a system biology approach
Gastroenterology and Hepatology from Bed to Bench,
Vol. 17 No. 4 (2024),
2 December 2024
https://doi.org/10.22037/ghfbb.v17i4.3013
Abstract
Aim: Molecular mechanism detection of stage I to stage II transition of esophageal squamous cell carcinoma via protein-protein interaction (PPI) network analysis is the main aim of this study.
Background: Esophageal cancer (EC) is recognized as cancer with a very poor prognosis and malignancy. It is characterized by a high prevalence rate within the world and a very low survival rate, even with treatment.
Methods: To detect esophageal squamous cell carcinoma (ESCC) related genes, gene expression profiles (GEPs) of GSE161533 from the Gene Expression Omnibus (GEO) database were considered to be analyzed. Data was evaluated via the GEO2R program to explore the significant differential genes (DEGs) associated to stages I and II of esophageal squamous cell carcinoma. Each analysis's top 250 significant DEGs were evaluated, and the non-common genes were assessed via PPI network analysis. The hub-bottleneck DEGs were determined and enriched via gene ontology.
Results: Results indicate 373 significant DEGs discriminate stage I from stage II. PPI network analysis associated with gene expression assessment showed that COL1A1, SERPINE1, PDGFRB, AURKA, TGFBI, LGALS3, BRCA1, and TFRC are the critical DEGs which are related to ESCC transition state from stage I to II of disease. A total of 13 biological processes and molecular functions were related to the crucial genes.
Conclusion: In conclusion, the Upregulation of COL1A1, SERPINE1, PDGFRB, AURKA, TGFB1, and LGALS3 and downregulation of BRCA1 and TFRC in stage II of ESCC relative to stage I were pointed out as the key events which are associated with promotion of stage I to stage II transition.
- Expression pattern
How to Cite
References
Tella SH, Mara K, Chakrabarti S, Jin Z, Mahipal A. A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data. Journal of Gastrointestinal Oncology. 2023;14(1):1. https://pubmed.ncbi.nlm.nih.gov/36915445/
Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iranian journal of public health. 2018;47(3):309. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971166/
Cameniţă D, Demetrian AD, Pleşea RM, Tănasie-Vasile MI, Strambu VDE, Grigorean VT, et al. Clinical–morphological profiles of esophageal carcinoma’s main types. Romanian Journal of Morphology and Embryology. 2020;61(2):407. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864308/
Berry MF. Esophageal cancer: staging system and guidelines for staging and treatment. Journal of thoracic disease. 2014;6(Suppl 3):S289. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037413/
Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current status and future prospects for esophageal cancer. Cancers. 2023;15(3):765. https://pubmed.ncbi.nlm.nih.gov/36765722/
Fu L, Qin YR, Xie D, Chow HY, Ngai SM, Kwong DL, et al. Identification of alpha‐actinin 4 and 67 kDa laminin receptor as stage‐specific markers in esophageal cancer via proteomic approaches. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2007;110(12):2672-81. https://pubmed.ncbi.nlm.nih.gov/17960614/
Safari-Alighiarloo N, Taghizadeh M, Rezaei-Tavirani M, Goliaei B, Peyvandi AA. Protein-protein interaction networks (PPI) and complex diseases. Gastroenterology and Hepatology from bed to bench. 2014;7(1):17. https://pubmed.ncbi.nlm.nih.gov/25436094/
Abbaszadeh H-A, Peyvandi AA, Sadeghi Y, Safaei A, Zamanian-Azodi M, Khoramgah MS, et al. Er: YAG laser and cyclosporin A effect on cell cycle regulation of human gingival fibroblast cells. Journal of lasers in medical sciences. 2017;8(3):143. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662504/
Nithya C, Kiran M, Nagarajaram HA. Dissection of hubs and bottlenecks in a protein-protein interaction network. Computational Biology and Chemistry. 2023;102:107802. https://pubmed.ncbi.nlm.nih.gov/36603332/
Rezaei-Tavirani M, Rezaei-Tavirani S, Mansouri V, Rostami-Nejad M, Rezaei-Tavirani M. Protein-protein interaction network analysis for a biomarker panel related to human esophageal adenocarcinoma. Asian Pacific journal of cancer prevention: APJCP. 2017;18(12):3357. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980895/
Jiang S, Zhang Q, Su Y, Pan L. Network-based differential analysis to identify molecular features of tumorigenesis for esophageal squamous carcinoma. Molecules. 2018;23(1):88. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017464/
Rezaei-Tavirani M, Rezaei-Tavirani S, Ahmadi N, Naderi N, Abdi S. Pancreatic adenocarcinoma protein-protein interaction network analysis. Gastroenterology and Hepatology from bed to bench. 2017;10(Suppl1):S85. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838186/
Karbalaei R, Piran M, Rezaei-Tavirani M, Asadzadeh-Aghdaei H, Heidari MH. A systems biology analysis protein-protein interaction of NASH and IBD based on comprehensive gene information. Gastroenterology and hepatology from bed to bench. 2017;10(3):194. https://pubmed.ncbi.nlm.nih.gov/29118935/
Zhou J, Zhao L-Q, Xiong M-M, Wang X-Q, Yang G-R, Qiu Z-L, et al. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World journal of gastroenterology. 2003;9(1):9. https://pubmed.ncbi.nlm.nih.gov/12508342/
Li J, Wang X, Zheng K, Liu Y, Li J, Wang S, et al. The clinical significance of collagen family gene expression in esophageal squamous cell carcinoma. PeerJ. 2019;7:e7705. https://pubmed.ncbi.nlm.nih.gov/31598423/
Lv J, Guo L, Wang J-H, Yan Y-Z, Zhang J, Wang Y-Y, et al. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett’s esophagus. World journal of gastroenterology. 2019;25(2):233. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337015/
Klimczak‑Bitner AA, Kordek R, Bitner J, Musiał J, Szemraj J. Expression of MMP9, SERPINE1 and miR‑134 as prognostic factors in esophageal cancer. Oncology letters. 2016;12(5):4133-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104243/
Song G, Liu K, Yang X, Mu B, Yang J, He L, et al. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB. Oncotarget. 2017;8(11):17771. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392285/
Liu B, Xiao X, Lin Z, Lou Y, Zhao L. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer. Cancer Biomarkers. 2022;34(2):251-64. https://pubmed.ncbi.nlm.nih.gov/34958001/
Han L, Wu Z, Zhao Q. Revealing the molecular mechanism of colorectal cancer by establishing LGALS3‑related protein-protein interaction network and identifying signaling pathways. International journal of molecular medicine. 2014;33(3):581-8. https://www.spandidos-publications.com/10.3892/ijmm.2014.1620
Song L, Tang J-w, Owusu L, Sun M-Z, Wu J, Zhang J. Galectin-3 in cancer. Clinica chimica acta. 2014;431:185-91. https://pubmed.ncbi.nlm.nih.gov/24530298/
Katsha A, Arras J, Soutto M, Belkhiri A, El-Rifai W. AURKA regulates JAK2–STAT3 activity in human gastric and esophageal cancers. Molecular oncology. 2014;8(8):1419-28. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254172/
Ozawa D, Yokobori T, Sohda M, Sakai M, Hara K, Honjo H, et al. TGFBI expression in cancer stromal cells is associated with poor prognosis and hematogenous recurrence in esophageal squamous cell carcinoma. Annals of surgical oncology. 2016;23:282-9. https://pubmed.ncbi.nlm.nih.gov/25448803/
Zhang X, Wei J, Zhou L, Zhou C, Shi J, Yuan Q, et al. A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. Carcinogenesis. 2013;34(10):2309-13. https://pubmed.ncbi.nlm.nih.gov/23749772/
Wei B, Han Q, Xu L, Zhang X, Zhu J, Wan L, et al. Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma. BMC cancer. 2015;15:1-11. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1364-0
Wada S, Noguchi T, Takeno S, Kawahara K. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma. Annals of surgical oncology. 2006;13:961-6. https://pubmed.ncbi.nlm.nih.gov/16788758/
- Abstract Viewed: 156 times
- PDF Downloaded: 7 times